Genetic factors in colorectal cancerColorectal Cancer Surgical TreatmentsColorectal Cancer Treatments and Studies

Adjuvant therapy in stage II-III colon cancer: 3 vs. 6 months, MSI-H, ctDNA integration

Carles Pericay Pijaume, Marta Monteis Pla, Esther Falcó Ferrer, Julen Fernández Plana

DOI: 10.20960/revcancer.00137

要旨

要旨は利用できません。

PIJAUME, Carles Pericay, et al. Adjuvant therapy in stage II-III colon cancer: 3 vs. 6 months, MSI-H, ctdna integration. Revisiones en Cancer, 2026.